The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Open accessAbstract
Statins are 3-hydroxy-3-methyglutaryl coenzyme A (HMG-CoA) reductase inhibitors, which are prescribed extensively for cholesterol lowering in the primary and secondary prevention of cardiovascular disease. Recent compelling evidence suggests that the beneficial effects of statins may not only be due to their cholesterol lowering effects, but also, to their cholesterol-independent or pleiotropic effects. Through these so-called pleiotropic effects, statins are directly involved in restoring or improving endothelial function, attenuating vascular remodeling, inhibiting vascular inflammatory response, and perhaps, stabilizing atherosclerotic plaques. These cholesterol-independent effects of statins are predominantly due to their ability to inhibit isoprenoid synthesis, the products of which are important lipid attachments for intracellular signaling molecules, such as Rho, Rac and Cdc42. In particular, inhibition of Rho and its downstream target, Rho-associated coiled-coil containing protein kinase (ROCK), has emerged as the principle mechanisms underlying the pleiotropic effects of statins. This review provides an update of statin-mediated vascular effects beyond cholesterol lowering and highlights recent findings from bench to bedside to support the concept of statin pleiotropy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591 · cited 1×
“Interestingly, eNOS is also a substrate of Akt and is phosphorylated at Ser 1177/1179 [58].”
BackgroundActivation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Brown, B. G., Ganz, P., Vogel, R. A., Crowe, T., Howard, G., Cooper, C. J., Brodie, B., et al. (2004) · JAMA · doi:10.1001/jama.291.9.1071 · Cited by 2,361
Rho GTPases and signaling networks
Van Aelst, L., & D’Souza-Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Garg, U. C., & Hassid, A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114081 · Cited by 2,155
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
ROCKs: multifunctional kinases in cell behaviour
Riento, K., & Ridley, A. J. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1128 · Cited by 1,941
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Self-citationDe Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Self-citationStimulation of Bone Formation in Vitro and in Rodents by Statins
Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,774
Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,750
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Alberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
Burridge, K., & Wennerberg, K. (2004) · Cell · doi:10.1016/s0092-8674(04)00003-0 · Cited by 1,578
Rosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Effect of pravastatin on outcomes after cardiac transplantation
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331003 · Cited by 1,301 · cited 1×
“Recent studies have shown that statins can attenuate cytokine-mediated VSMC proliferation in coronary artery smooth muscle cells and also inhibit pathological proliferation such as that observed in transplant-associated arteriopathy [72-74].”
BackgroundSimvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Kastelein, J. J. P., Akdim, F., Stroes, E. S. G., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F. H., Visseren, F. L. J., Sijbrands, E. J. G., Trip, M. D., Stein, E. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800742 · Cited by 1,241
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,213
Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rütten, H., Fichtlscherer, S., Martin, H., & Zeiher, A. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13152 · Cited by 1,211
Iso, H., Jacobs, D. R., Wentworth, D., Neaton, J. D., Cohen, J. D., & for the MRFIT Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201405 · Cited by 1,133
Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P., & Ganz, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320802 · Cited by 1,109
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035 · cited 2×
“Although the effects of statins on Ras and Rho isoprenylation are reversed in the presence of FPP and GGP, respectively, the effects of statins on eNOS expression are reversed only by GGPP, but not by FPP or LDL cholesterol [56].”
BackgroundSelf-citationVasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A. M., & Dimmeler, S. (2001) · Circulation · doi:10.1161/hc2401.092816 · Cited by 1,018
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001
Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 1,001
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966
Self-citationSimvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O'Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 952
Translational Control of p27 Kip1 Accumulation During the Cell Cycle
Hengst, L., & Reed, S. I. (1996) · Science · doi:10.1126/science.271.5257.1861 · Cited by 846
Healey, J. S., Baranchuk, A., Crystal, E., Morillo, C. A., Garfinkle, M., Yusuf, S., & Connolly, S. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.070 · Cited by 822
Vidal-Puig, A. J., Considine, R. V., Jimenez-Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 786
Amarenco, P., Labreuche, J., Lavallée, P., & Touboul, P.-J. (2004) · Stroke · doi:10.1161/01.str.0000147965.52712.fa · Cited by 746
Brouilette, S. W., Moore, J. S., McMahon, A. D., Thompson, J. R., Ford, I., Shepherd, J., Packard, C. J., & Samani, N. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60071-3 · Cited by 745
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H., Kawamoto, A., Walsh, K., Isner, J. M., & Asahara, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13131 · Cited by 709
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
Greenwood, J., Steinman, L., & Zamvil, S. S. (2006) · Nature Reviews Immunology · doi:10.1038/nri1839 · Cited by 683
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
Sudhop, T., Lütjohann, D., Kodal, A., Igel, M., Tribble, D. L., Shah, S., Perevozskaya, I., & von Bergmann, K. (2002) · Circulation · doi:10.1161/01.cir.0000034044.95911.dc · Cited by 682
Statins Have Biphasic Effects on Angiogenesis
Weis, M., Heeschen, C., Glassford, A. J., & Cooke, J. P. (2002) · Circulation · doi:10.1161/hc0602.103393 · Cited by 680
Platelet Function in Hyperlipoproteinemia
Carvalho, A. C. A., Colman, R. W., & Lees, R. S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197402212900805 · Cited by 679
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 623
Reciprocal Regulation of Endothelial Nitric-oxide Synthase by Ca2+-Calmodulin and Caveolin
Michel, J. B., Feron, O., Sacks, D., & Michel, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15583 · Cited by 613
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Wang, C.-Y., Liu, P.-Y., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 593
Self-citationAikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P. (2001) · Circulation · doi:10.1161/01.cir.103.2.276 · Cited by 588
Fernández-Ortiz, A., Badimon, J. J., Falk, E., Fuster, V., Meyer, B., Mailhac, A., Weng, D., Shah, P. K., & Badimon, L. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90657-2 · Cited by 587
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 574
Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
Tamai, O., Matsuoka, H., Itabe, H., Wada, Y., Kohno, K., & Imaizumi, T. (1997) · Circulation · doi:10.1161/01.cir.95.1.76 · Cited by 542
Wagner, A. H., Köhler, T., Rückschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 516
Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure
Li, J.-M., Gall, N. P., Grieve, D. J., Chen, M., & Shah, A. M. (2002) · Hypertension · doi:10.1161/01.hyp.0000032031.30374.32 · Cited by 516
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13350 · Cited by 491
Self-citationRegulation of reactive-oxygen-species generation in fibroblasts by Rac 1
SUNDARESAN, M., YU, Z.-X., FERRANS, V. J., SULCINER, D. J., GUTKIND, S., IRANI, K. J., GOLDSCHMIDT-CLERMONT, P. J., & FINKEL, T. (1996) · Biochemical Journal · doi:10.1042/bj3180379 · Cited by 486
Statins for Improving Renal Outcomes: A Meta-Analysis
Sandhu, S., Wiebe, N., Fried, L. F., & Tonelli, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010012 · Cited by 478
Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase
Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H., & Liao, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000020682.73694.ab · Cited by 475
Self-citationOral simvastatin treatment in relapsing-remitting multiple sclerosis
Vollmer, T., Key, L., Durkalski, V., Tyor, W., Corboy, J., Markovic-Plese, S., Preiningerova, J., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 469
Shibuya, M., Suzuki, Y., Sugita, K., Saito, I., Sasaki, T., Takakura, K., Nagata, I., Kikuchi, H., Takemae, T., Hidaka, H., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.4.0571 · Cited by 466
Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
Fuster, V., Stein, B., Ambrose, J. A., Badimón, L., Badimón, J. J., & Chesebro, J. H. (1990) · PubMed · Cited by 454
Lacoste, L., Lam, J. Y. T., Hung, J., Letchacovski, G., Solymoss, C. B., & Waters, D. (1995) · Circulation · doi:10.1161/01.cir.92.11.3172 · Cited by 441
Landmesser, U., Bahlmann, F., Mueller, M., Spiekermann, S., Kirchhoff, N., Schulz, S., Manes, C., Fischer, D., de Groot, K., Fliser, D., et al. (2005) · Circulation · doi:10.1161/01.cir.0000164260.82417.3f · Cited by 425
Maack, C., Kartes, T., Kilter, H., Schäfers, H.-J., Nickenig, G., Böhm, M., & Laufs, U. (2003) · Circulation · doi:10.1161/01.cir.0000091084.46500.bb · Cited by 423
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000100688.17280.e6 · Cited by 421
Feron, O., Dessy, C., Desager, J.-P., & Balligand, J.-L. (2001) · Circulation · doi:10.1161/01.cir.103.1.113 · Cited by 417
Node, K., Fujita, M., Kitakaze, M., Hori, M., & Liao, J. K. (2003) · Circulation · doi:10.1161/01.cir.0000084539.58092.de · Cited by 414
Self-citationPleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 407
Strippoli, G. F. M., Navaneethan, S. D., Johnson, D. W., Perkovic, V., Pellegrini, F., Nicolucci, A., & Craig, J. C. (2008) · BMJ · doi:10.1136/bmj.39472.580984.ae · Cited by 402
Laufs, U., Gertz, K., Huang, P., Nickenig, G., Böhm, M., Dirnagl, U., & Endres, M. (2000) · Stroke · doi:10.1161/01.str.31.10.2442 · Cited by 390
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 387
Self-citationThe effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386
Fukumoto, Y., Libby, P., Rabkin, E., Hill, C. C., Enomoto, M., Hirouchi, Y., Shiomi, M., & Aikawa, M. (2001) · Circulation · doi:10.1161/01.cir.103.7.993 · Cited by 384
National Cancer Institute (2020) · Definitions · doi:10.32388/f3vp5p · Cited by 383
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
Koh, K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00146-2 · Cited by 380
Laufs, U., Marra, D., Node, K., & Liao, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21926 · Cited by 380
Self-citationCyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
Role of Platelet-Activating Factor in Cardiovascular Pathophysiology
Montrucchio, G., Alloatti, G., & Camussi, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1669 · Cited by 371
Discovery, biochemistry and biology of lovastatin
Alberts, A. W. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90002-1 · Cited by 358
Wassmann, S., Laufs, U., Bäumer, A. T., Müller, K., Konkol, C., Sauer, H., Böhm, M., & Nickenig, G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12257-2 · Cited by 345
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure
Horwich, T. B., MacLellan, W. R., & Fonarow, G. C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.049 · Cited by 341
S‐nitroso‐glutathione inhibits platelet activation in vitro and in vivo
Radomski, M. W., Rees, D. D., Dutra, A., & Moncada, S. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14517.x · Cited by 326
Simvastatin Preserves the Ischemic-Reperfused Myocardium in Normocholesterolemic Rat Hearts
Lefer, A. M., Campbell, B., Shin, Y.-K., Scalia, R., Hayward, R., & Lefer, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.2.178 · Cited by 326
The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits
Brown, J. H., Del Re, D. P., & Sussman, M. A. (2006) · Circulation Research · doi:10.1161/01.res.0000216039.75913.9e · Cited by 323
Werns, S. W., Walton, J. A., Hsia, H. H., Nabel, E. G., Sanz, M. L., & Pitt, B. (1989) · Circulation · doi:10.1161/01.cir.79.2.287 · Cited by 322
Michel, J. B., Feron, O., Sase, K., Prabhakar, P., & Michel, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25907 · Cited by 320
Essig, M., Nguyen, G., Prié, D., Escoubet, B., Sraer, J.-D., & Friedlander, G. (1998) · Circulation Research · doi:10.1161/01.res.83.7.683 · Cited by 316
Aviram, M., Rosenblat, M., Bisgaier, C. L., & Newton, R. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00032-x · Cited by 296
Cell cycle-specific effects of lovastatin.
Jakóbisiak, M., Bruno, S., Skierski, J. S., & Darzynkiewicz, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3628 · Cited by 295
Statin Therapy and Risks for Death and Hospitalization in Chronic Heart Failure
Go, A. S., Lee, W. Y., Yang, J., Lo, J. C., & Gurwitz, J. H. (2006) · JAMA · doi:10.1001/jama.296.17.2105 · Cited by 291
Davenpeck, K. L., Gauthier, T. W., & Lefer, A. M. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90229-1 · Cited by 281
Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation
Fauchier, L., Pierre, B., de Labriolle, A., Grimard, C., Zannad, N., & Babuty, D. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.063 · Cited by 272
Requirement of Rac1 in the development of cardiac hypertrophy
Satoh, M., Ogita, H., Takeshita, K., Mukai, Y., Kwiatkowski, D. J., & Liao, J. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510444103 · Cited by 272
Self-citationBauersachs, J., Galuppo, P., Fraccarollo, D., Christ, M., & Ertl, G. (2001) · Circulation · doi:10.1161/hc3401.095946 · Cited by 263
Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities
Rosenson, R. S. (2004) · Atherosclerosis · doi:10.1016/s0021-9150(03)00239-9 · Cited by 260
Gauthier, T. W., Scalia, R., Murohara, T., Guo, J.-P., & Lefer, A. M. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1652 · Cited by 242
Tavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Yano, M., Matsumura, T., Senokuchi, T., Ishii, N., Murata, Y., Taketa, K., Motoshima, H., Taguchi, T., Sonoda, K., Kukidome, D., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000268411.49545.9c · Cited by 235
ToddBourcier, & PeterLibby (2000) · Arteriosclerosis Thrombosis and Vascular Biology · Cited by 233
Colhoun, H. M., Betteridge, D. J., & Durrington, P. N. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.017 · Cited by 229
G Proteins and Small GTPases: Distant Relatives Keep in Touch
Hall, A. (1998) · Science · doi:10.1126/science.280.5372.2074 · Cited by 217
Scalia, R., Gooszen, M. E., Jones, S. P., Hoffmeyer, M., Rimmer, D. M., Trocha, S. D., Huang, P. L., Smith, M. B., Lefer, A. M., & Lefer, D. J. (2001) · Circulation · doi:10.1161/01.cir.103.21.2598 · Cited by 204
Stalker, T. J., Lefer, A. M., & Scalia, R. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704070 · Cited by 202
Impact of HMG CoA reductase inhibition on small GTPases in the heart
Laufs, U. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00540-5 · Cited by 202
Sawada, N., Itoh, H., Ueyama, K., Yamashita, J., Doi, K., Chun, T.-H., Inoue, M., Masatsugu, K., Saito, T., Fukunaga, Y., et al. (2000) · Circulation · doi:10.1161/01.cir.101.17.2030 · Cited by 195
Chandrasekar, B., Mummidi, S., Mahimainathan, L., Patel, D. N., Bailey, S. R., Imam, S. Z., Greene, W. C., & Valente, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600200200 · Cited by 193
Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Zhu, W., Kadowaki, T., & Yazaki, Y. (1999) · Circulation Research · doi:10.1161/01.res.84.4.458 · Cited by 188
Germershausen, J. I., Hunt, V. M., Bostedor, R. G., Bailey, P. J., Karkas, J. D., & Alberts, A. W. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92773-3 · Cited by 170
Paumelle, R., Blanquart, C., Briand, O., Barbier, O., Duhem, C., Woerly, G., Percevault, F., Fruchart, J.-C., Dombrowicz, D., Glineur, C., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202706.70992.95 · Cited by 165
Vogt, A., Qian, Y., McGuire, T. F., Hamilton, A. D., & Sebti, S. M. (1996) · PubMed · Cited by 164
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
LaRosa, J. C., Grundy, S. M., & Waters, D. D. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.10.023 · Cited by 163
Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses
Clerk, A., Cullingford, T. E., Fuller, S. J., Giraldo, A., Markou, T., Pikkarainen, S., & Sugden, P. H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21094 · Cited by 160
Senthil, V., Chen, S. N., Tsybouleva, N., Halder, T., Nagueh, S. F., Willerson, J. T., Roberts, R., & Marian, A. J. (2005) · Circulation Research · doi:10.1161/01.res.0000177090.07296.ac · Cited by 159
Nissen, S. E., Tuzcu, E. M., & Al, P. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.04.030 · Cited by 157
Lefer, A. M., Campbell, B., Scalia, R. G., & Lefer, D. J. (1998) · Circulation · doi:10.1161/01.cir.98.13.1322 · Cited by 155
Dechend, R., Fiebeler, A., Park, J.-K., Müller, D. N., Theuer, J., Mervaala, E. M. A., Bieringer, M., Gulba, D. C., Dietz, R., Luft, F. C., et al. (2001) · Circulation · doi:10.1161/hc3001.092039 · Cited by 153
Zelvyté, I., Dominaitiene, R., Crisby, M., & Janciauskiene, S. M. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0922 · Cited by 152
Statins and Mortality Among Elderly Patients Hospitalized With Heart Failure
Foody, J. M., Shah, R., Galusha, D. H., Masoudi, F. A., Havranek, E. P., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.105.591446 · Cited by 152
Characterization of risk factors for vascular dementia: The Honolulu–Asia Aging Study
Ross, G. W., Petrovitch, H., White, L. R., Masaki, K., Li, C. Y., Curb, J. D., Yano, K., Rodríguez, B. L., Foley, D. J., Blanchette, P. L., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.337 · Cited by 151
Schwartz, G. G., OLSSON, A. G., & al, M. D. E. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00368-3 · Cited by 151
Rezaie-Majd, A., Prager, G. W., Bucek, R. A., Schernthaner, G.-H., Maca, T., Kress, H. G., Valent, P., Binder, B. R., Minar, E., & Baghestanian, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000059384.34874.f0 · Cited by 146
Gregg, D., Rauscher, F. M., & Goldschmidt‐Clermont, P. J. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2003 · Cited by 145
Fichtlscherer, S., Schmidt‐Lucke, C., Bojunga, S., Rössig, L., Heeschen, C., Dimmeler, S., & Zeiher, A. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi881 · Cited by 140
Rasmussen, L. M., Hansen, P. R., NABIPOUR, M. T., Olesen, P., Kristiansen, M. T., & Ledet, T. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600363 · Cited by 134
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells
Mulhaupt, F. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00515-7 · Cited by 134
Rapid Regulation of Platelet Activation In Vivo by Nitric Oxide
Schäfer, A., Wiesmann, F., Neubauer, S., Eigenthaler, M., Bauersachs, J. K., & Channon, K. M. (2004) · Circulation · doi:10.1161/01.cir.0000126837.88743.dd · Cited by 133
Endothelium as a Therapeutic Target in Heart Failure
Drexler, H. (1998) · Circulation · doi:10.1161/01.cir.98.24.2652 · Cited by 125
Simvastatin Attenuates Oxidant-Induced Mitochondrial Dysfunction in Cardiac Myocytes
Jones, S. P., Teshima, Y., Akao, M., & Marbán, E. (2003) · Circulation Research · doi:10.1161/01.res.0000097262.21507.df · Cited by 124
Huhle, G., Abletshauser, C., Mayer, N., Weidinger, G., Harenberg, J., & Heene, D. L. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00037-7 · Cited by 123
Statin Protects Endothelial Nitric Oxide Synthase Activity in Hypoxia-Induced Pulmonary Hypertension
Murata, T., Kinoshita, K., Hori, M., Kuwahara, M., Tsubone, H., Karaki, H., & Ozaki, H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186184.33537.48 · Cited by 123
Blanquart, C., Mansouri, R. M., Paumelle, R., Fruchart, J., Staels, B., & Glineur, C. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0327 · Cited by 115
Elucidation off the role of plaque instability and rupture in acute coronary events
Fuster, V. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80467-6 · Cited by 113
Perspectives in Cholesterol-Lowering Therapy
Bruckert, É., Giral, P., & Tellier, P. (2003) · Circulation · doi:10.1161/01.cir.0000072345.98581.24 · Cited by 112
Augmented oxidative stress of platelets in chronic smokers
Takajo, Y., Ikeda, H., Haramaki, N., Murohara, T., & Imaizumi, T. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01583-2 · Cited by 109
Sata, M., Nishimatsu, H., Suzuki, E., Sugiura, S., Yoshizumi, M., Ouchi, Y., Hirata, Y., & Nagai, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0415fje · Cited by 109
Wagner, A. H., Gebauer, M., Güldenzoph, B., & Hecker, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000037098.20829.31 · Cited by 109
New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering
Palinski, W. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.3 · Cited by 108
Statin therapy in Alzheimer's disease
Sparks, D. L., Sabbagh, M., Connor, D. J., Soares, H. D., Lopez, J., Stankovic, G. R., Johnson‐Traver, S., Ziolkowski, C. H. J., & Browne, P. J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00689.x · Cited by 105
N-WASP, WAVE and Mena play different roles in the organization of actin cytoskeleton in lamellipodia
Nakagawa, H., Miki, H., Ito, M., Ohashi, K., Takenawa, T., & Miyamoto, S. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.8.1555 · Cited by 104
Yang, Z., Kozai, T., van der Loo, B., Viswambharan, H., Lachat, M. L., Turina, M. I., Maliñski, T., & Lüscher, T. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00924-4 · Cited by 104
Small GTP-binding proteins and their regulators in cardiac hypertrophy
Lezoualc’h, F., Metrich, M., Hmitou, I., Duquesnes, N., & Morel, É. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.01.011 · Cited by 101
Corti, R., Osende, J. I., Fallon, J. T., Fuster, V., Mizsei, G., Jneid, H. M., Wright, S. D., Chaplin, W. F., & Badimón, J. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.048 · Cited by 100
Shimizu, K., Aikawa, M., Takayama, K., Libby, P., & Mitchell, R. N. (2003) · Circulation · doi:10.1161/01.cir.0000092949.67153.74 · Cited by 99
Chung, H. K., Lee, I. K., Kang, H., Suh, J. M., Kim, H., Park, K. C., Kim, D. W., Kim, Y. K., Ro, H. K., & Shong, M. (2002) · Experimental & Molecular Medicine · doi:10.1038/emm.2002.63 · Cited by 96
Therapeutic potential of lovastatin in multiple sclerosis
Sena, A., Pedrosa, R., & Morais, M. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1070-8 · Cited by 96
Repression of IFN-γ Expression by Peroxisome Proliferator-Activated Receptor γ
Cunard, R. A., Eto, Y., Muljadi, J. T., Glass, C. K., Kelly, C., & Ricote, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7530 · Cited by 89
Intensive versus moderate lipid lowering with statins after acute coronary syndromes*
(2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000133105.83326.47 · Cited by 80
Statin Therapy for Stroke Prevention
Nassief, A. M., & Marsh, J. D. (2008) · Stroke · doi:10.1161/strokeaha.107.501361 · Cited by 77
Hauck, L., Harms, C., Grothe, D., An, J., Gertz, K. R., Kronenberg, G., Dietz, R., Endres, M., & von Harsdorf, R. (2006) · Circulation Research · doi:10.1161/01.res.0000254704.92532.b9 · Cited by 75
Liao, J. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99973-4 · Cited by 72
Self-citationHealey, J., Baranchuk, A., & Crystal, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.243 · Cited by 72
Higuchi, Y., Otsu, K., Nishida, K., Hirotani, S., Nakayama, H., Yamaguchi, O., Hikoso, S., Kashiwase, K., Takeda, T., Watanabe, T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213203200 · Cited by 70
Haramaki, N., Ikeda, H., Takenaka, K., Katoh, A., Sugano, R., Yamagishi, S., Matsuoka, H., & Imaizumi, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.128793 · Cited by 68
Improved Lymphocyte Function-associated Antigen-1 (LFA-1) Inhibition by Statin Derivatives
Weitz‐Schmidt, G., Welzenbach, K., Dawson, J., & Kallen, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407951200 · Cited by 67
Platelet-Derived Nitric Oxide and Coronary Risk Factors
Ikeda, H., Takajo, Y., Murohara, T., Ichiki, K., Adachi, H., Haramaki, N., Katoh, A., & Imaizumi, T. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.904 · Cited by 61
Li, M., Liu, Y., Dutt, P., Fanburg, B. L., & Toksoz, D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00133.2007 · Cited by 60
Opper, C., Clement, C., Schwarz, H., Krappe, J., Steinmetz, A., Schneider, J. E., & Wesemann, W. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05448-r · Cited by 53
Control of signal transduction and morphogenesis by Ras
Hughes, D. A. (1995) · Seminars in Cell Biology · doi:10.1016/1043-4682(95)90005-5 · Cited by 48
Differential Modulation of Caveolin-1 Expression in Cells of the Vasculature by Statins
Plenz, G. A. M., Hofnagel, O., & Robenek, H. (2004) · Circulation · doi:10.1161/01.cir.0000111128.83347.7a · Cited by 47
Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen, P., Echevaría-Vázquez, D., & Petrov, V. (1996) · PubMed · Cited by 43
Statin therapy in Alzheimer's disease
Kivipelto, M., Solomon, A., & Winblad, B. G. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70150-2 · Cited by 43
Additive Effects of Statin and Dipyridamole on Cerebral Blood Flow and Stroke Protection
Kim, H.-H., Sawada, N., Soydan, G., Lee, H.-S., Zhou, Z., Hwang, S., Waeber, C., Moskowitz, M. A., & Liao, J. K. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.24 · Cited by 41
Self-citationHale, L. P., Craver, K., Berrier, A. M., Sheffield, M. V., Case, L. D., & Owen, J. D. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.10.1643 · Cited by 37
Treatment and prevention of atrial fibrillation with nonantiarrhythmic pharmacologic therapy
Lozano, H. F., Conde, C. A., Florin, T., & Lamas, G. A. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.05.020 · Cited by 32
Simvastatin With or Without Ezetimibe in Familial Hypercholesterolemia
Chen, L. (2008) · Journal of Evidence-Based Medicine · Cited by 31
(2009) · Clinical Governance An International Journal · doi:10.1108/cgij.2009.24814bae.005 · Cited by 15
Statin therapy is associated with improved survival in ischemic and nonischemic heart failure
Horwich, T. B., Hamilton, M. A., MacLeilan, R., Patel, J. K., Lesniewski, M., & Fonarow, G. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)81801-6 · Cited by 12
C-Reactive Protein Levels and Outcomes After Statin Therapy
Howard, W. J. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70304-4 · Cited by 4
Cited by
Paul, S., & Candelario-Jalil, E. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113518 · Cited by 748
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Zhou, Q., & Liao, J. K. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0110 · Cited by 567
Self-citationDrug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
Rho-kinase: Regulation, (dys)function, and inhibition
Amin, E., Dubey, B. N., Zhang, S.-C., Gremer, L., Dvorsky, R., Moll, J. M., Taha, M. S., Nagel-Steger, L., Piekorz, R. P., Somlyo, A. V., et al. (2013) · bchm · doi:10.1515/hsz-2013-0181 · Cited by 176
Kandelouei, T., Abbasifard, M., Imani, D., Aslani, S., Razi, B., Fasihi, M., Shafiekhani, S., Mohammadi, K., Jamialahmadi, T., Reiner, Ž., et al. (2022) · Mediators of Inflammation · doi:10.1155/2022/8732360 · Cited by 136
Metadata
- Authors
- Zhou, Q., & Liao, J.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-02-01
- Volume
- 15
- Issue
- 5
- Pages
- 467-478
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2033554531
- Cited by
- 294
- References
- 180
- FWCI
- 16.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.